Nantahala Capital Management, LLC Q3 2023 Filing

Filed November 14, 2023

Portfolio Value

$1.2B

Holdings

120

Report Date

Q3 2023

Filing Type

13F-HR

All Holdings (120 positions)

#StockSharesValue% PortfolioType
101
SRTSSENSUS HEALTHCARE INC
185,048$512.6B43785.36%
102
TILINSTIL BIO INC
1,000,000$428.0B36560.20%
103
APSGBPAPTOSE BIOSCIENCES INC
136,483$382.2B32643.81%
104
LADRLADDER CAP CORP
27,073$277.8B23727.31%
105
XGNEXAGEN INC
106,769$258.4B22071.17%
106
ELTXELICIO THERAPEUTICS INC
30,000$253.5B21654.23%
107
ADCTADC THERAPEUTICS SA
257,162$230.7B19704.41%
108
TACTTRANSACT TECHNOLOGIES INC
31,108$199.7B17059.69%
109
LUCDLUCID DIAGNOSTICS INC
158,135$185.0B15804.43%
110
BM TECHNOLOGIES INC
79,212$158.4B13532.74%
111
AKUMIN INC
979,196$142.9B12203.67%
112
RFLRAFAEL HLDGS INC
72,678$138.1B11795.62%
113
DMPIEURKINTARA THERAPEUTICS INC
22,619$91.4B7805.86%
114
GAIAGAIA INC NEW
23,144$63.0B5377.42%
115
CUECUE BIOPHARMA INC
26,760$61.5B5257.49%
116
GFAIGUARDFORCE AI CO LTD
154,205$54.0B4610.34%
117
GYRECATALYST BIOSCIENCES INC
67,800$32.7B2793.27%
118
NOGIN INC
56,425$30.0B2559.38%
119
NOGIN INC
330,000$13.3B1135.33%
120
TCBWFTC BIOPHARM HOLDINGS PLC
235,294$5.2B442.14%
PreviousPage 2 of 2